Next Article in Journal
Evaluation of Candidatus Liberibacter Asiaticus Efflux Pump Inhibition by Antimicrobial Peptides
Previous Article in Journal
ZnO Nanostructures Doped with Various Chloride Ion Concentrations for Efficient Photocatalytic Degradation of Methylene Blue in Alkaline and Acidic Media
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Correction

Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597

1
Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY 12144, USA
2
Department of Biochemistry, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
3
Department of Hematology/Pediatric Oncology, Yousef Abdulatif Jameel Scientific Chair of Prophetic Medicine Application, Faculty of Medicine, King Abdulaziz University, Jeddah 21589, Saudi Arabia
*
Author to whom correspondence should be addressed.
Molecules 2022, 27(24), 8730; https://doi.org/10.3390/molecules27248730
Submission received: 29 August 2022 / Accepted: 14 November 2022 / Published: 9 December 2022

Error in Figure

In the original publication [1], there was an error in the representative images for PBS (control) and RQ-NPs (10× and 40×), which were mistakenly duplicated while arranging the figure from the control and the RQ-NPs sets of the cardiac tissue slice images. Corrected representative images at 10× and 40× are placed from the RQ-NP treated group cardiac tissue slices. The authors apologize for this unintentional mistake. These changes in the representative images do not affect the conclusions regarding the biological activity of the RQ-NP with or without Dox studied as shown in Figure 6.
Corrected Figure 6:
Molecules 27 08730 i001

Reference

  1. Godugu, K.; El-Far, A.H.; Al Jaouni, S.; Mousa, S.A. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Godugu, K.; El-Far, A.H.; Al Jaouni, S.; Mousa, S.A. Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597. Molecules 2022, 27, 8730. https://doi.org/10.3390/molecules27248730

AMA Style

Godugu K, El-Far AH, Al Jaouni S, Mousa SA. Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597. Molecules. 2022; 27(24):8730. https://doi.org/10.3390/molecules27248730

Chicago/Turabian Style

Godugu, Kavitha, Ali H. El-Far, Soad Al Jaouni, and Shaker A. Mousa. 2022. "Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597" Molecules 27, no. 24: 8730. https://doi.org/10.3390/molecules27248730

APA Style

Godugu, K., El-Far, A. H., Al Jaouni, S., & Mousa, S. A. (2022). Correction: Godugu et al. Nanoformulated Ajwa (Phoenix Dactylifera) Bioactive Compounds Improve the Safety of Doxorubicin without Compromising Its Anticancer Efficacy in Breast Cancer. Molecules 2020, 25, 2597. Molecules, 27(24), 8730. https://doi.org/10.3390/molecules27248730

Article Metrics

Back to TopTop